Elotuzumab Market Current and Future Industry Landscape Analysis 2034
Elotuzumab Market Overview: A monoclonal antibody called Elotuzumab is used to treat multiple myeloma, a malignancy that attacks the bone marrow's plasma cells. The increased frequency of multiple myeloma and the growing need for targeted medicines in cancer are driving growth in the global market for elotuzumab. By selectively targeting the SLAMF7 protein present on myeloma cells,...
0 Commenti 0 condivisioni 588 Views 0 Anteprima